A cross-ethnic analysis of risk factors for AD in white hispanics and white non-hispanics

Neurology

Volumn 52, Issue 3, 1999, Pages 551-556

  Harwood, D G ^a   Barker, W W ^a   Loewenstein, D A ^a   Ownby, R L ^a   St George Hyslop, P ^b   Mullan, M ^c   Duara, Ranjan ^a,d  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

^d MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACADEMIC ACHIEVEMENT; ALCOHOL CONSUMPTION; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; ETHNIC DIFFERENCE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SMOKING;

EID: 0033051646     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.52.3.551     Document Type: Article

References (43)

1. Myers RH, Schaefer EJ, Wilson PW, et al. Apolipoprotein E epsilon 4 association with dementia in a population-based study: the Framingham study. Neurology 1996;46:673-677.
2. Farrer LA, Cupples LA, Haines JL, et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: a meta-analysis. JAMA 1997; 278:1349-1356.
3. Corder EH, Saunders AM, Risch NJ, et al. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer's disease. Nature Genet 1994;7:180-184.
4. Tang M, Stern Y, Marder K, et al. The apoE-ε4 allele and the risk of Alzheimer's disease among African Americans, whites, and Hispanics. JAMA 1998;279:751-755.
5. American Association of Retired Persons. A profile of older Americans (publication no. PF3049). Washington, DC: American Association of Retired Persons, 1994.
6. Adroer R, Santacruz P, Blesa R, Lopez-Pousa S, Ascaso C, Oliva R. Apolipoprotein ε4 allele frequency in Spanish Alzheimer and control cases. Neurosci Lett 1995;189:182-186.
7. Ibarreta D, Gomez-Isla T, Portera-Sanchez A, Parrilla R, Ayuso, MS. Apolipoprotein E genotype in Spanish patients with Alzheimer's or Parkinson's disease. J Neurol Sci 1995; 134:146-149.
8. Duara R, Barker WW, Lopez-Alberola R, et al. Alzheimer's disease: interaction of apolipoprotein E genotype, family history of dementia, gender, education, ethnicity, and age of onset. Neurology 1996;46:1575-1579.
9. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease. Neurology 1984;34:939-944.
10. Folstein M, Folstein S, McHugh P. Mini-mental state. A practical method for grading the cognitive state of patients for the physician. J Psychosom Res 1975;12:189-198.
11. Crum RM, Anthony JC, Bassett SS, Folstein MF. Population-based norms for the Mini-Mental State Examination by age and educational level. JAMA 1993;269:2386-2391.
12. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62.
13. Tsuda T, Lopez R, Rogaeva EA, et al. Are the associations between Alzheimer's disease and polymorphisms in the apolipoprotein E and the apolipoprotein CII genes due to linkage disequilibrium? Ann Neurol 1994;36:97-100.
14. Wenham PR, Price WH, Blundell G. Apolipoprotein E genotyping by one stage PCR. Lancet 1991;337:1158-1159.
15. van Duijn CM, Hofman A, Kay DWK. Risk factors for Alzheimer's disease: a collaborative reanalysis of case-control studies. Int J Epidemiol 1991;20(suppl 2):S1-S3.
16. Zekraoui L, Lucotte G, Raisonnier A. Apolipoprotein E genotypes in Africa: allelic frequencies and ethnic groups. Presented at the Ibsen Foundation Meeting; May 29, 1995; Paris.
17. Mullan M, Scibelli P, Duara R, et al. Familial and population-based studies of apolipoprotein E and Alzheimer's disease. Ann NY Acad Sci 1996;802:16-26.
18. Tang M-X, Maestre G, Tsai W-Y, et al. Relative risk of Alzheimer disease and age-at-onset distributions, based on APOE genotypes among elderly African Americans, Caucasians, and Hispanics in New York City. Am J Hum Genet 1996;58:574-584.
19. Rocca WA, Bonaiuto S, Lippi A, et al. Prevalence of clinically diagnosed Alzheimer's disease and other dementing disorders: a door-to-door survey in Appignano, Maceerata Province, Italy. Neurology 1990;40:626-631.
20. Fratiglioni L, Ahlbom A, Viitanen M, Winblad B. Risk factors for late-onset Alzheimer's disease: a population-based, case-control study. Ann Neurol 1993;33:258-266.
21. Friedland RP. Epidemiology, education, and the ecology of Alzheimer's disease. Neurology 1993;43:246-249.
22. Rao VS, Cupples LA, Auerbach SA, et al. Age at onset of Alzheimer's disease is influenced by multiple genetic and non-genetic factors: the Mirage Study. Alzheimer Res 1995;1:159-168.
23. Graves AB, van Duijn CM, Chandra V, et al. Alcohol and tobacco consumption as risk factors for Alzheimer's disease: a collaborative re-analysis of case-control studies. Int J Epidemiol 1991;20(suppl 2):S48-S57.
24. Hebert LE, Scherr PA, Beckett LA, et al. Relation of smoking and alcohol consumption to incident Alzheimer's disease. Am J Epidemiol 1992;135:347-355.
25. Salib E, Hillier V. Head injury and the risk of Alzheimer's disease: a case control study. Int J Geriatr Psychiatry 1997; 12:363-368.
26. Graves AB, White E, Koepsell TD, et al. The association between head trauma and Alzheimer's disease. Am J Epidemiol 1990;131:491-501.
27. Chandra V, Kokmen E, Schoenberg BS, Beard CM. Head trauma with loss of consciousness as a risk factor for Alzheimer's disease. Neurology 1989;39:1576-1578.
28. Mendez MF, Underwood KL, Zander BA, Mastri AR, Sung JH, Frey WH II. Risk factors in Alzheimer's disease: a clinico-pathologic study. Neurology 1992;42:770-775.
29. Ott A, Slooter AJC, Hofman A, et al. Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study: the Rotterdam Study. Lancet 1998;351:1840-1843.
30. Broe GA, Henderson AS, Creasey H, et al. A case-control study of Alzheimer's disease in Australia. Neurology 1990;40: 1698-1707.
31. Paganini-Hill A, Henderson VW. Estrogen deficiency and risk of Alzheimer's disease in women. Am J Epidemiol 1994;140: 256-261.
32. Tang M, Jacobs D, Stern Y, et al. Effect of estrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 1996;348:429-432.
33. Brett KM, Madans JH. Use of postmenopausal hormone replacement therapy: estimates from a nationally representative cohort study. Am J Epidemiol 1997;145:536-545.
34. Skoog I, Lernfelt B, Landahl S, et al. Fifteen-year longitudinal study of blood pressure and dementia. Lancet 1996;347:1141-1145.
35. Lindsay J, Hebert R, Rockwood K. The Canadian Study of Health and Aging: risk factors for vascular dementia. Stroke 1997;28:526-530.
36. Launer LJ, Masaki K, Petrovitch H, Foley D, Havlik RJ. The association between midlife blood pressure levels and late-life cognitive function. The Honolulu-Asia Aging Study. JAMA 1995;274:1846-1851.
37. Rockwood K, Lindsay J, McDowell I. High blood pressure in dementia. Lancet 1996;348:65.
38. Angel, JL, Angel RJ. Age at migration, social connections, and well-being among elderly Hispanics. J Aging Health 1992;4: 480-499.
39. Haynes SG, Harvey C, Montes H, Nickens H, Cohen BH. Patterns of cigarette smoking among Hispanics in the United States: results from HHANES 1982-84. Am J Public Health 1990;80:47-53.
40. Cangiano JL. Hypertension in Hispanic Americans. Cleve Clin J Med 1994;61:345-350.
41. Mortimer JA. The epidemiology of Alzheimer's disease: beyond risk factors. In: Iqbal K, Mortimer JA, Winblad B, Wisniewski HM, eds. Research advances in Alzheimer's disease and related disorders. New York: John Wiley & Sons, 1995:3-16.
42. Jonker C, Launer LJ, Hooijer C, Lindeboom J. Memory complaints and memory impairment in older individuals. J Am Geriatr Soc 1996;44:44-49.
43. Schofield PW, Marder K, Dooneief G, Jacobs DM, Sano M, Stern Y. Association of subjective memory complaints with subsequent cognitive decline in community-dwelling elderly individuals with baseline cognitive impairment. Am J Psychiatry 1997;154:609-615.